OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells is a paramount challenge with the biopharmaceutical industry. Various strategies are employed maximize antibody titer, including process parameter optimization, cell line development, and adoption of perfusion systems. Fine-tuning growth parameters plays a